Skip to content
Open access

Clinical, genetic, and instrumental features of congenital myasthenic syndrome type 11

Sep 2026 · Neuromuscular Diseases · 0 citations · 30 references

TL;DR

The phenotypic spectrum of CMS type 11 is characterized by a wide phenotypic spectrum – from a mild limb-girdle phenotype with extraocular involvement and childhood onset to severe forms with neonatal manifestation and respiratory failure, and early orthopedic complications.

Abstract

Background. Congenital myasthenic syndrome (CMS) type 11, caused by pathogenic biallelic variants in the RAPSN gene, is one of the most common forms of CMS in patients of European origin. The disease is characterized by significant clinical heterogeneity, which, combined with the variability of electrophysiological findings, leads to diagnostic challenges. Accurate diagnosis determines the management strategy, enabling symptomatic treatment and improvement of functional outcomes. Aim. To characterize the phenotypic spectrum of CMS type 11 and evaluate genotype–phenotype features based on clinical and instrumental examination of a cohort of patients with biallelic variants in the RAPSN gene. Materials and methods. The study included 6 patients (4 female) from 5 families with a verified diagnosis of CMS type 11. All patients underwent molecular genetic testing: whole exome sequencing in all cases; in one case, whole genome sequencing using a targeted gene panel for myopathies and myasthenic syndromes was additionally performed, followed by Sanger sequencing validation of identified variants. Variant pathogenicity was assessed according to ACMG/APM (2015) criteria. All patients underwent clinical and genealogical analysis and laboratory testing (creatine phosphokinase, alanine aminotransferase, aspartate aminotransferase, lactate dehydrogenase, myoglobin). Electrodiagnostic evaluation in 5 patients included neuromuscular transmission testing at 3 Hz repetitive nerve stimulation and needle electromyography of skeletal muscles; in two cases the protocol was extended – one patient underwent stimulation at 10 Hz and another at 50 Hz. Muscle magnetic resonance imaging was performed in 3 patients. Results. Molecular genetic analysis identified the recurrent variant in RAPSN (NM_005055.5): c.264CA, p.(Asn88Lys) in all patients: in homozygous state in 4 patients, and in compound heterozygous state in 2 patients – in combination with c.61CT, p.(Gln21Ter) and c.149_153delins24, p.(Val50GlufrTer114). In patients with the homozygous c.264CA variant, the disease manifested in childhood or adolescence and followed a relatively mild course, presenting with blepharoptosis, oculomotor disturbances, and predominantly limb-girdle distribution of pathological muscle fatigability and weakness, without bulbar or respiratory involvement. In patients with compound heterozygous variants, the disease manifested in the neonatal period with respiratory failure requiring mechanical ventilation, diffuse muscular hypotonia, and bulbar dysfunction, and was accompanied by delayed motor development, recurrent episodes of respiratory failure, and early orthopedic complications. Repetitive nerve stimulation at 3 Hz revealed a decremental response exceeding 30 % in 1 of 5 examined patients; preconditioning with physical exercise allowed verification of a decrement of 10–16 % in 2 additional patients. Needle electromyography in all 5 patients demonstrated a myopathic pattern of motor unit potential remodeling. Muscle magnetic resonance imaging in 3 patients revealed minimal fatty infiltration predominantly in the posterior muscle groups of the thighs and legs, combined with diffuse edematous changes in the posterior leg muscles. All patients with the homozygous recurrent variant and one patient with compound heterozygous variants received pyridostigmine bromide therapy with a positive clinical response. Conclusion. CMS type 11 is characterized by a wide phenotypic spectrum – from a mild limb-girdle phenotype with extraocular involvement and childhood onset to severe forms with neonatal manifestation and respiratory failure. Disease severity is determined by the zygosity of the c.264CA variant: in homozygous state it is associated with a mild late-onset phenotype, whereas in compound heterozygous combination with another pathogenic allele it is associated with neonatal manifestation and severe course. A myopathic pattern of motor unit potential remodeling on needle electromyography, combined with absent decrement on 3 Hz repetitive stimulation and minimal muscle magnetic resonance imaging changes, should not exclude CMS from the differential diagnosis with congenital myopathies. Timely molecular genetic verification of CMS determines the feasibility of symptomatic treatment and is of critical importance for prognosis and patient management.

Read PDF

Similar papers

Open access Aug 2026

Exploring the clinical and mutational spectrum of MORC2-associated disorders.

It is demonstrated that early-onset MORC2-associated disorders segregate into two principal neurological phenotypes: a predominantly neuromuscular form and a central nervous system-predominant form.

A. Murtazina, Eugenii Tatarsky, I. Viakhireva et al. · 0 citations
Review Open access Sep 2026

Independent coexistence of diseases in neurogenetics: case reports and literature review

13 patients from 12 families with two hereditary diseases of the nervous system, verified by DNA analysis, are described and 8 gene variants are identified, 8 of which have not been previously described.

G. Rudenskaya, A. Kuchina, E. Melnik et al. · 0 citations
Sep 2026

Allgrove syndrome in Colombia: clinical characterization and evidence of a possible founder effect

A highly prevalent AAAS variant suggestive of a possible founder effect was identified in the Paisa population and expanded the phenotypic spectrum and underscore the importance of early genetic testing and systematic multidisciplinary surveillance.

Johana Andrea Botero Hernandez, Eder Donadoni Varela Macias, María Victoria Lopera Cañaveral et al. · 0 citations
Case report Sep 2026

[Clinical characterization and genetic analysis of a patient with Fahr disease due to a homozygous variant of JAM2 gene].

The patient had developed unsteady gait 6 months before without clear cause, manifesting as a feeling of heaviness in the head and lightness in the feet, a sensation of walking on cotton wool when standing or walking, and the detection of the novel variant has enriched the mutational spectrum of the JAM2 gene.

Qian Ma, Wen-Jun Shao, Yi-Wei Wang et al. · 0 citations
Sep 2026

[Analysis of clinical spectrum and genotype characteristics of 9 cases of Fabry disease].

Atypical presentations in patients with Fabry disease exhibit a broad clinical spectrum and diverse genotypes and should be closely monitored to enable early diagnosis and treatment, thereby improving prognosis.

Z.-J. He, Y.-Y. Zhang, Lin Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.